These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6276786)

  • 1. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK; Allikmets LH; Zarkovsky AM
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):36-7. PubMed ID: 6276786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR; Algeri S; Stramentinoli G
    Pharmacol Res Commun; 1987 Mar; 19(3):231-40. PubMed ID: 3602044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of certain GABA-ergic substances on dopamine metabolism in the rat brain].
    Malikova LA; Arefolov VA
    Farmakol Toksikol; 1981; 44(1):37-40. PubMed ID: 6790298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
    Bredeloux P; Dubuc I; Costentin J
    Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
    Pavlík A; Benesová O; Dlohozková N
    Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL; Nair NP; Bozarth M
    Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
    Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.
    Gandolfi O; Rimondini R; Dall'Olio R
    Neuropharmacology; 1992 Nov; 31(11):1111-4. PubMed ID: 1335556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical effects of quipazine on rat striatal dopaminergic system.
    Ponzio F; Consolazione A; Calderini G; Achilli G; Rocchetti M; Algeri S
    Life Sci; 1981 Jul; 29(1):83-91. PubMed ID: 7266263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.